Cargando…
Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis
Intravenous adipose mesenchymal stem cells (ADSCs) attenuate renal ischemia/reperfusion (IR) injury but with major drawbacks, including the lack of a specific homing effect after systemic infusion, cell trapping in the lung, and early cell death in the damaged microenvironment. We examined whether i...
Autores principales: | Cheng, Yu-Hsuan, Chen, Kuo-Hsin, Sung, Yi-Ting, Yang, Chih-Ching, Chien, Chiang-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495781/ https://www.ncbi.nlm.nih.gov/pubmed/36139786 http://dx.doi.org/10.3390/antiox11091702 |
Ejemplares similares
-
Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014) -
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020) -
Ameliorative Effect of Recombinant Human Erythropoietin and Ischemic Preconditioning on Renal Ischemia Reperfusion Injury in Rats
por: Elshiekh, Mohammed, et al.
Publicado: (2015) -
Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017) -
Ischaemic preconditioning and pharmacological preconditioning with dexmedetomidine in an equine model of small intestinal ischaemia-reperfusion
por: König, Kathrin S., et al.
Publicado: (2020)